QuickView for TNRC13;jsessionid=3D765BD25ABDC6EF1EDE0A75B9F1BD6C;jsessionid=F814328285108F7A4EA0DA28CFE696D7;jsessionid=502E776C630F24248151AAEED05D5B46;jsessionid=3D6E4177C1A2C936A25F58E22CF119FE;jsessionid=37B596B4B55CD3647D0279084925B569;jsessionid=447DC72F2F1C3DA9A78FBFD88360156A;jsessionid=44678BF73A6C52B27863CAD2D6B7D1CE;jsessionid=8A3E99373A3B0241963364D75A0FAA34;jsessionid=80D046FD8BC112A23B541EE1BCB499B9 (gene)

1. Ataxin-2 sequesters Raptor into aggregates and impairs cellular mTORC1 signaling.
2. The polyglutamine protein ATXN2: from its molecular functions to its involvement in disease.
3. Clinical features, disease progression, and nuclear imaging in ATXN2-related parkinsonism in a longi…
4. ATXN2 is a target of N-terminal proteolysis.
5. A Case of Coexistent Spinocerebellar Ataxia Type 2 and Primary Progressive Multiple Sclerosis-Coinci…

There were no clinical trials for TNRC13;jsessionid=3D765BD25ABDC6EF1EDE0A75B9F1BD6C;jsessionid=F814328285108F7A4EA0DA28CFE696D7;jsessionid=502E776C630F24248151AAEED05D5B46;jsessionid=3D6E4177C1A2C936A25F58E22CF119FE;jsessionid=37B596B4B55CD3647D0279084925B569;jsessionid=447DC72F2F1C3DA9A78FBFD88360156A;jsessionid=44678BF73A6C52B27863CAD2D6B7D1CE;jsessionid=8A3E99373A3B0241963364D75A0FAA34;jsessionid=80D046FD8BC112A23B541EE1BCB499B9